The levonorgestrel-releasing intrauterine system may represent an effective treatment option in >85% of endometrial hyperplasia cases, but histologic regression during and/or at the end of treatment does not assure stable recovery. We recommend periodic endometrial samplings for at least the first 2 years of follow-up and long-term clinical surveillance thereafter.
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study / G. Scarselli; G. Bargelli; G. Taddei; M. Marchionni; E. Peruzzi; A. Pieralli; A. Mattei; A. Buccoliero; M. Fambrini. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - ELETTRONICO. - ..:(2011), pp. 0-0.
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.
SCARSELLI, GIANFRANCO;TADDEI, GIAN LUIGI;MARCHIONNI, MAURO;PIERALLI, ANNALISA;BUCCOLIERO, ANNA MARIA;FAMBRINI, MASSIMILIANO
2011
Abstract
The levonorgestrel-releasing intrauterine system may represent an effective treatment option in >85% of endometrial hyperplasia cases, but histologic regression during and/or at the end of treatment does not assure stable recovery. We recommend periodic endometrial samplings for at least the first 2 years of follow-up and long-term clinical surveillance thereafter.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0015028210021503-main.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
73.16 kB
Formato
Adobe PDF
|
73.16 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
